The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Elevated thyroid stimulating hormone levels are associated with metabolic syndrome in euthyroid young women

  • Oh, Jee-Young (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Sung, Yeon-Ah (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Lee, Hye Jin (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • Published : 2013.03.01
⟨ Previous Next ⟩

Abstract

Background/Aims: The existence of an association between thyrotropin (thyroid stimulating hormone, TSH) levels and metabolic derangement in euthyroid subjects is controversial. We examined the association between high normal TSH levels and metabolic syndrome in healthy young women. Methods: The study recruited 2,760 young female volunteers (age, 18 to 39 years) with TSH levels in the normal range (0.3 to 4.5 mU/L). We defined metabolic syndrome using the 2007 International Diabetes Federation criteria. Using a TSH level of 2.5 mU/L as an upper reference limit, as recommended by the National Academy of Clinical Biochemistry, we divided the subjects into high- (n = 453) and low-TSH groups (n = 2,307). Results: The prevalence of metabolic syndrome was significantly higher in the high-TSH group than in the low-TSH group (7.5% vs. 4.8%, p = 0.016). Central obesity (22.3% vs. 17.3%, p = 0.012) and hypertriglyceridemia (8.0% vs. 4.2%, p = 0.0007) were significantly more frequent in the high-TSH group than in the low-TSH group. Waist circumference, systolic and diastolic blood pressure, and triglycerides were significantly associated with the TSH level after adjusting for age and body mass index (BMI). Subjects in the high-TSH group had a 2-fold greater risk of metabolic syndrome than subjects in the low-TSH group after adjusting for age and BMI (odds ratio, 1.9; 95% confidence interval, 1.1 to 3.2). Conclusions: Healthy young women with TSH levels > 2.5 mU/L should be assessed for the presence of metabolic syndrome, even if their TSH levels are in the normal range.

Keywords

References

  1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497. https://doi.org/10.1001/jama.285.19.2486
  2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;365:1415-1428. https://doi.org/10.1016/S0140-6736(05)66378-7
  3. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509. https://doi.org/10.1056/NEJM200102153440707
  4. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab 2003;88:2438-2444. https://doi.org/10.1210/jc.2003-030398
  5. Asvold BO, Vatten LJ, Nilsen TI, Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study: the HUNT Study. Eur J Endocrinol 2007;156:181-186. https://doi.org/10.1530/eje.1.02333
  6. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 2007;92:491-496. https://doi.org/10.1210/jc.2006-1718
  7. Chubb SA, Davis WA, Davis TM. Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study. J Clin Endocrinol Metab 2005;90:5317-5320. https://doi.org/10.1210/jc.2005-0298
  8. Kratzsch J, Fiedler GM, Leichtle A, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005;51:1480-1486. https://doi.org/10.1373/clinchem.2004.047399
  9. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411. https://doi.org/10.1210/jc.2003-030242
  10. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000;132:270-278.
  11. Park HT, Cho GJ, Ahn KH, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 2009;62:301-305. https://doi.org/10.1016/j.maturitas.2009.01.007
  12. Nader NS, Bahn RS, Johnson MD, Weaver AL, Singh R, Kumar S. Relationships between thyroid function and lipid status or insulin resistance in a pediatric population. Thyroid 2010;20:1333-1339. https://doi.org/10.1089/thy.2010.0180
  13. Paoli-Valeri M, Guzman M, Jimenez-Lopez V, Arias-Ferreira A, Briceno-Fernandez M, Arata-Bellabarba G. Atherogenic lipid profile in children with subclinical hypothyroidism. An Pediatr (Barc) 2005;62:128-134. https://doi.org/10.1157/13071309
  14. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002;8:457-469. https://doi.org/10.4158/1934-2403-8.6.457
  15. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003;13:3-126. https://doi.org/10.1089/105072503321086962
  16. Fatourechi V, Klee GG, Grebe SK, et al. Effects of reducing the upper limit of normal TSH values. JAMA 2003;290:3195-3196. https://doi.org/10.1001/jama.290.24.3195-a
  17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. https://doi.org/10.1007/BF00280883
  18. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301. https://doi.org/10.2337/diacare.23.3.295
  19. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol 2010;316:165-171. https://doi.org/10.1016/j.mce.2009.06.005
  20. Onur S, Haas V, Bosy-Westphal A, et al. L-tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol 2005;152:179-184. https://doi.org/10.1530/eje.1.01850
  21. Nyrnes A, Jorde R, Sundsfjord J. Serum TSH is positively associated with BMI. Int J Obes (Lond) 2006;30:100-105. https://doi.org/10.1038/sj.ijo.0803112
  22. Tagliaferri M, Berselli ME, Calo G, et al. Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res 2001;9:196-201. https://doi.org/10.1038/oby.2001.21
  23. Knudsen N, Laurberg P, Rasmussen LB, et al. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90:4019-4024. https://doi.org/10.1210/jc.2004-2225
  24. Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. Thyroid hormones and their relation to weight status. Horm Res 2008;70:51-57. https://doi.org/10.1159/000129678
  25. Winter WE, Signorino MR. Review: molecular thyroidology. Ann Clin Lab Sci 2001;31:221-244.
  26. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004;291:228-238. https://doi.org/10.1001/jama.291.2.228
  27. Pallas D, Koutras DA, Adamopoulos P, et al. Increased mean serum thyrotropin in apparently euthyroid hypercholesterolemic patients: does it mean occult hypothyroidism? J Endocrinol Invest 1991;14:743-746. https://doi.org/10.1007/BF03347907
  28. Bakker SJ, ter Maaten JC, Popp-Snijders C, Slaets JP, Heine RJ, Gans RO. The relationship between thyrotropin and low density lipoprotein cholesterol is modified by insulin sensitivity in healthy euthyroid subjects. J Clin Endocrinol Metab 2001;86:1206-1211.
  29. Lithell H, Boberg J, Hellsing K, et al. Serum lipoprotein and apolipoprotein concentrations and tissue lipoprotein-lipase activity in overt and subclinical hypothyroidism: the effect of substitution therapy. Eur J Clin Invest 1981;11:3-10. https://doi.org/10.1111/j.1365-2362.1981.tb01758.x
  30. Liu XQ, Rahman A, Bagdade JD, Alaupovic P, Kannan CR. Effect of thyroid hormone on plasma apolipoproteins and apoA- and apoB-containing lipoprotein particles. Eur J Clin Invest 1998;28:266-270. https://doi.org/10.1046/j.1365-2362.1998.00274.x
  31. Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with 'highnormal' TSH levels: should one extend the def inition of subclinical hypothyroidism? Eur J Endocrinol 1998;138:141-145. https://doi.org/10.1530/eje.0.1380141
  32. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction and blood pressure: a communitybased study. Clin Endocrinol (Oxf) 2006;65:486-491. https://doi.org/10.1111/j.1365-2265.2006.02619.x
  33. Liu D, Jiang F, Shan Z, et al. A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens 2010;24:134-138. https://doi.org/10.1038/jhh.2009.44
  34. Duan Y, Peng W, Wang X, et al. Community-based study of the association of subclinical thyroid dysfunction with blood pressure. Endocrine 2009;35:136-142. https://doi.org/10.1007/s12020-008-9138-y
  35. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J 2011;35:303-308. https://doi.org/10.4093/dmj.2011.35.4.303
  36. McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-464. https://doi.org/10.2337/diacare.24.3.460

Cited by

  1. "High normal" thyroid stimulating hormone: does it matter? vol.28, pp.2, 2013, https://doi.org/10.3904/kjim.2013.28.2.162
  2. Serum Free Thyroxine Concentration is Associated with Metabolic Syndrome in Euthyroid Subjects vol.24, pp.11, 2013, https://doi.org/10.1089/thy.2014.0103
  3. Thyroid function in adult Nigerians with metabolic syndrome vol.18, pp.None, 2013, https://doi.org/10.11604/pamj.2014.18.352.4551
  4. The prevalence of the metabolic syndrome increases through the quartiles of thyroid stimulating hormone in a population-based sample of euthyroid subjects. vol.58, pp.9, 2014, https://doi.org/10.1590/0004-2730000003538
  5. Thyroid function is associated with insulin resistance markers in healthy adolescents with risk factors to develop diabetes vol.7, pp.None, 2013, https://doi.org/10.1186/s13098-015-0011-x
  6. Subclinical Hypothyroidism and Cardiovascular Disease vol.30, pp.3, 2013, https://doi.org/10.3803/enm.2015.30.3.246
  7. Pattern of Thyroid Dysfunction in Patients with Metabolic Syndrome and Its Relationship with Components of Metabolic Syndrome vol.39, pp.1, 2015, https://doi.org/10.4093/dmj.2015.39.1.66
  8. Thyrotropin Levels, Insulin Resistance, and Metabolic Syndrome: A Cross-Sectional Analysis in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) vol.13, pp.8, 2015, https://doi.org/10.1089/met.2015.0045
  9. Negative Association between Obesity Index and Thyroid Hormones in Euthyroid Children vol.24, pp.4, 2015, https://doi.org/10.7570/kjo.2015.24.4.212
  10. Inositol(s) in thyroid function, growth and autoimmunity vol.17, pp.4, 2013, https://doi.org/10.1007/s11154-016-9370-3
  11. Relationship between metabolic syndrome and thyroid nodules in healthy Koreans vol.31, pp.1, 2013, https://doi.org/10.3904/kjim.2016.31.1.98
  12. Super-sensitive time-resolved fluoroimmunoassay for thyroid-stimulating hormone utilizing europium(III) nanoparticle labels achieved by protein corona stabilization, short binding time, and serum prep vol.409, pp.13, 2013, https://doi.org/10.1007/s00216-017-0284-z
  13. Variations in Serum Free Thyroxine Concentration Within the Reference Range Predicts the Incidence of Metabolic Syndrome in Non-Obese Adults: A Cohort Study vol.27, pp.7, 2013, https://doi.org/10.1089/thy.2016.0557
  14. Thyroid function and metabolic syndrome in the population-based LifeLines cohort study vol.17, pp.1, 2013, https://doi.org/10.1186/s12902-017-0215-1
  15. The Study on the Correlation between Serum Levels of Thyroid Stimulating Hormone and Metabolic Syndrome in Euthyroid Young Adults vol.8, pp.7, 2018, https://doi.org/10.12677/acm.2018.87101
  16. The association between thyroid function and incidence of metabolic syndrome in euthyroid subjects: Tianjin chronic low‐grade systemic inflammation and health cohort study vol.88, pp.5, 2013, https://doi.org/10.1111/cen.13576
  17. Thyroid function in obese Korean children and adolescents: Korea National Health and Nutrition Examination Survey 2013–2015 vol.23, pp.3, 2013, https://doi.org/10.6065/apem.2018.23.3.141
  18. The Relationship between Thyroid Function and Different Obesity Phenotypes in Korean Euthyroid Adults vol.43, pp.6, 2013, https://doi.org/10.4093/dmj.2018.0130
  19. Association between serum thyrotropin within the euthyroid range and obesity vol.66, pp.5, 2013, https://doi.org/10.1507/endocrj.ej18-0140
  20. High Normal Range of Free Thyroxine is Associated with Decreased Triglycerides and with Increased High-Density Lipoprotein Cholesterol Based on Population Representative Data vol.8, pp.6, 2013, https://doi.org/10.3390/jcm8060758
  21. Role of Adipokines in the Association between Thyroid Hormone and Components of the Metabolic Syndrome vol.8, pp.6, 2013, https://doi.org/10.3390/jcm8060764
  22. High TSH Level within Normal Range Is Associated with Obesity, Dyslipidemia, Hypertension, Inflammation, Hypercoagulability, and the Metabolic Syndrome: A Novel Cardiometabolic Marker vol.8, pp.6, 2019, https://doi.org/10.3390/jcm8060817
  23. Associations Between Thyroid Hormones Within the Euthyroid Range and Indices of Obesity in Obese Chinese Women of Reproductive Age vol.17, pp.8, 2019, https://doi.org/10.1089/met.2019.0036
  24. The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population vol.13, pp.None, 2020, https://doi.org/10.2147/dmso.s252154
  25. The role of thyroid hormone in metabolism and metabolic syndrome vol.11, pp.None, 2020, https://doi.org/10.1177/2042018820917869
  26. Thyroid hormone levels are associated with metabolic components: a cross-sectional study vol.61, pp.3, 2020, https://doi.org/10.3325/cmj.2020.61.230
  27. Thyroid Dysfunction in Metabolic Syndrome Patients in a Tertiary Care Hospital vol.9, pp.30, 2013, https://doi.org/10.14260/jemds/2020/459
  28. Association of thyroid hormones with metabolic syndrome and its components in postmenopausal Chinese women vol.36, pp.8, 2013, https://doi.org/10.1080/09513590.2020.1749997
  29. Epidemiology of metabolic syndrome and its components in Chinese patients with a range of thyroid-stimulating hormone concentrations vol.48, pp.11, 2020, https://doi.org/10.1177/0300060520966878
  30. Association between blood lead levels and metabolic syndrome considering the effect of the thyroid-stimulating hormone based on the 2013 Korea National health and nutrition examination survey vol.15, pp.12, 2013, https://doi.org/10.1371/journal.pone.0244821
  31. Association between TSH Values and GFR Levels in Euthyroid Cases with Metabolic Syndrome vol.2021, pp.None, 2013, https://doi.org/10.1155/2021/8891972
  32. The Relationship Between Thyroid Function and Metabolic Syndrome and Its Components: A Cross-Sectional Study in a Chinese Population vol.12, pp.None, 2021, https://doi.org/10.3389/fendo.2021.661160
  33. Association between triglyceride-glucose index and thyroid function in euthyroid adults: The Korea National Health and Nutritional Examination Survey 2015 vol.16, pp.7, 2013, https://doi.org/10.1371/journal.pone.0254630
  34. Lower normal free thyroxine is associated with a higher risk of metabolic syndrome: a retrospective cohort on Chinese population vol.21, pp.1, 2013, https://doi.org/10.1186/s12902-021-00703-y